Newsfiscal.ai
Emergent BioSolutions Receives $22.3 Million Anthrax Vaccine Contract Modification
· Published
Article summary
Emergent BioSolutions has secured a contract modification from the U.S. Department of Defense valued at up to $22.3 million to supply its BioThrax vaccine.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…